As PARTIQoL was a negative study, what is the current role for proton therapy in the management of prostate cancer patients?
2
2 AnswersMednet Member
Radiation Oncology · Michigan Healthcare Professionals, PC
Thank you for the comprehensive answer Dr. @Dr. First Last!
It is interesting you talk about integral dose - that almost rarely comes up from the patient in my experience. They have read and have been told that it IS less toxic (not that it may be). They are told that protons are better and the auth...
Mednet Member
Radiation Oncology
PARTIQoL was a randomized study of proton vs. photon beam therapy (PBT) for low-intermediate risk prostate cancer (T1-T2c N0 M0, ≤GG3, PSA < 20). Patients were treated with RT alone without ADT. Treatment volumes included the prostate to a full dose, the bilateral SVs to a prophylactic dose, and exc...